GSK Enters Agreement to Acquire Aiolos Bio

Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway



AIO-001 could redefine the standard-of-care...

Related Keywords

London ,City Of ,United Kingdom ,China ,Brentford ,Hounslow ,Middlesex ,United Kingdom General ,San Francisco ,California ,United States ,Aiolos Bio ,Necdetb Gunsoy ,Ji Yeon Shin ,Lindam Nelsen ,Khurem Farooq ,Erics Bradford ,Roberty Suruki ,Frankc Albers ,Tony Wood ,Public Health ,Aiolos Bio Inc ,Jiangsu Hengrui Pharmaceuticals Co Ltd ,Greater China ,Chief Scientific Officer ,Chief Executive Officer ,Hart Scott Rodino Act ,United Kingdom Based ,Annual Report ,West Road ,Markets ,